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Abstract
Telomere length (TL) is considered a marker of biological aging and has been associated with
the presence of various coronary risk factors in patients. Much less is known about the rela-
tionships between TL and classic coronary risk factors in other populations. Wemeasured TL
in peripheral blood leukocytes of 343middle-aged blood donors (mean age 40.2 ± 12.4 years;
201men, 142 women) using quantitative polymerase chain reaction. Median TL was 0.86
(range: 0.48–1.85) relative TL units. In linear regression analyses with natural log-transformed
T to S ratio as the dependent variable, there was a significant association with age (per year:
beta = -0.007, p<0.001) and sex (males vs. females: beta = 0.075, p = 0.007) with longer telo-
meres in men. After adjusting for these two variables, we observed no association of TL with
classic coronary risk factors including cholesterol (p = 0.36), triglyceride (p = 0.09), HDL-cho-
lesterol (p = 0.26), LDL-cholesterol (p = 0.36), smoking (p = 0.97), and personal (p = 0.46) or
family history (p = 0.63) of cardiovascular disease. However, we did find a significant positive
association with white (p = 0.011) and red blood cell count (p = 0.031), hemoglobin (p = 0.014)
and hematocrit (p = 0.013); we also found a borderline positive association with thrombocytes
(p = 0.074). Positive associations remained significant for hemoglobin (p = 0.017), hematocrit
(p = 0.023), and leukocytes (p = 0.009) in a subgroup with no reported vascular disease; asso-
ciations were of borderline significance for erythrocytes (p = 0.053) and thrombocytes (p =
0.088) in this subgroup. The data do not support the concept that classic coronary risk factors
contribute to telomere attrition in a blood donor population. However, telomere attrition may be
amarker for reduced proliferation reserve in hematopoietic progenitor cells.
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Introduction
Telomeres are DNA protein complexes at the ends of linear chromosomes in eukaryotes that
serve a protective function during mitosis by stabilizing the chromosomal structure. Due to
inherent characteristics of the replication machinery in eukaryotes, and the so-called end-repli-
cation problem, TL shortens with each cell division and can be viewed as a mitotic clock reflect-
ing cellular turnover. Shortening to a critical length induces ‘replicative senescence’ via several
mechanisms, the most important of which seems to be a DNA damage-like response. Replica-
tive senescence includes replication arrest and may thus represent a tumor suppressor mecha-
nism protecting cells from transformation. As a drawback, however, telomere shortening limits
regenerative capacity. This fact has contributed to the development of the idea that TL can be
seen as a surrogate marker (and possibly also direct propagator) of the aging process and a
potential key to longevity. Furthermore, TL is being considered as a potential biomarker of
age-related chronic cardiovascular diseases, including atherosclerosis and heart failure [1,2]
because it reflects increased cellular stress and cell turnover in these diseases.
Indeed, several studies have shown an association between TL and coronary heart disease.
Shorter TLs were found in coronary endothelium of diseased coronary arteries [3] but were
also detectable in peripheral blood leukocytes of coronary heart disease patients [4–6]. Shorter
TLs were found in aneurysm biopsies [7] and in peripheral blood leukocytes of patients with
aortic aneurysms [8]. Reduced TLs were detected in leukocytes of hypertensive and diabetic
patients with carotid artery disease [9,10] and in leukocytes of patients with chronic heart fail-
ure suffering from peripheral vascular disease [11].
Less clear is the relationship between classic coronary risk factors and TL in apparently
healthy people. In the Framingham Study, hypertensive male subjects had shorter age-adjusted
TL than normotensive controls [12]. The Cardiovascular Health Study, however, could not
confirm these data in a mixed male and female cohort [6]. Leukocyte TL was also inversely
related to body mass index and diabetes mellitus in some studies [10,13,14]. But these correla-
tions were, if at all, only partially reproduced in other studies [15,16]. A dose-dependent effect
of smoking on telomere attrition was observed in two studies [13,17] but was not found in two
other studies [18,19]. In another study, no association between TL and lipid status or blood
pressure was observed in a middle-aged population [20].
In this study, we measured TL in peripheral blood leukocytes of middle-aged blood donors
and looked for associations between it and classic coronary risk factors and various so-called
emerging risk factors that may indicate the onset of organ dysfunction. To measure TL, we
used a high-end very precise PCR-based method.
Materials and Methods
Study design and determination of coronary risk factors
This study was approved by the Medical Ethical Committee Münster and all subjects provided
written informed consent. Blood donors were between 18 and 70 years old, and all participants
filled out an eligibility questionnaire disclosing any known health conditions or high-risk
behaviour before each blood donation. The rules of the blood donation center exclude any indi-
viduals from blood donation who have a hemoglobin lower than 12.5 mg/dl in women and
13.0 mg/dl in men, or who are suffering from chronic diseases or infections from blood dona-
tion. Body weight and blood pressure were recorded. Additionally a number of laboratory rou-
tine parameters including cholesterol, triglycerides, glucose, creatinine, and blood cell counts
were measured using autoanalyzers (Siemens, Roche). A total of 360 consecutively elected vol-
untary blood donors (210 men, 150 women) were eligible. We had TL measurements for 343
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out of these 360 eligibles. The missing 17 values are due to lack of sufficient DNA amounts or
DNA quality problems. Lifestyle factors, medical history, and demographics were recorded
using standardized questionnaires. These included: smoking (current smoking or non-smok-
ing), alcohol use, body weight, physical activity, diabetes, and blood pressure, as well as per-
sonal and family history of myocardial infarction, apoplexy, or other vascular disease. Alcohol
use was classified using an alcohol-index with three categories: abstention; moderate drinking
(less than three alcoholic drinks daily); and heavy drinking (three or more alcoholic drinks
daily). Body mass index (BMI) was calculated as weight divided by height squared (kg/m2).
Personal or family history of vascular disease was defined as the occurrence of myocardial
infarction, apoplexy, or any other vascular disease either in the blood donor, their parents, sib-
lings, and offspring, as reported by the donor in a questionnaire. The typical signs of peripheral
arterial or venous disease were described in the questionnaire as aching, cramping, pain or
swelling in the arms or legs, particularly when walking or exercising; feeling of heaviness in the
legs, and pain or cramps in the calves. The PROCAM (Prospective Cardiovascular Münster
Study) score was calculated using age, gender, diabetes mellitus (Y/N) or fasting blood glucose
levels> 120mg/dl (Y/N), current nicotine consumption (Y/N), positive family history of car-
diovascular disease (Y/N), systolic blood pressure in mmHg, LDL cholesterol, HDL cholesterol
and triglycerides.
Telomere length measurements and routine laboratory measurements
Mean TL was measured with the recently modified QPCR protocol using a single well strategy
to measure to the telomere (T) and single reference (S) signal [21]. The ratio of telomere and
reference gene content (T/S ratio) is a relative measure of TL and is expressed in arbitrary
units. A reference DNA standard (5.2 to 60 ng), a no template (water) control, and a positive/
maximum control (human leukemia cell line (1301) kindly provided by dr. Cesaro, IST,
Genova) were run in duplicate on each plate on a Bio-Rad CFX384 real-time C1000 thermal
cycler. Samples were run in triplicate on different plates. The final concentrations of reagents
in the PCR were 1U Titanium Taq DNA polymerase with the provided Titanium Taq PCR
buffer, 0.75xSYBR Green I (Sigma), 0.2 mM of each dNTP, 1 mMDTT, 1M betaine, 900nM of
each primer. The primers used were; telomere (T), telg, 5’-ACACTAAGGTTTGGGTTTGGG
TTTGGGTTTGGGTTAGTGT–3’ and telc, 5’-TGTTAGGTATCCCTATCCCTATCCCTAT
CCCTATCCCTAACA–3’, that generate a short, fixed-length product. The primers of the Sin-
gle copy gene (S) used were albu: 5’- cggcggcgggcggcgcgggctgggcggAAATGCTGCACAGAA
TCCTTG–3’ albd: 5’-gcccggcccgccgcgcccgtcccgccgGAAAAGCATGGTCGCCTGTT–3’. Lower
case letters of the albumin primers are non-template 5’ tag sequences that confer a high melting
temperature on resulting PCR product allowing monochrome multiplexing. The thermal
cycling profile was 15 min at 95°C; 2 cycles of 15 s at 94°C, 15 s at 49°C; 5 cycles of 15 s at 94°C,
15 s at 66°C; 32 cycles of 15 s at 94°C, 10 s at 60°C, 15 s at 72°C with T signal acquisition, 10 s
at 85°C, and 15 s at 89°C with S signal acquisition. For further explanation and details, see ref-
erence [21]. Reproducibility data was obtained for 343 independent subjects and good agree-
ment between T/S ratios was observed (R2 = 0.99, P<0.0001, inter-run CV 3.9%).
Statistical methods
Normally distributed continuous variables were presented as mean ± SD, and non-normally
distributed continuous variables were presented as median (range). As the ratio of telomere
and reference gene content (T/S ratio) showed a deviation from a normal distribution (Kolmo-
gorov–Smirnov test for normal distribution: p< 0.001), natural log-transformed T to S ratios
(Ln-T/S ratio) were used as surrogate parameters for TL (Kolmogorov–Smirnov test for
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normal distribution: p = 0.063, as shown in Fig 1). Dichotomous variables were presented as
total numbers and percentages. To test for differences between two independent subgroups
(males and females, Table 1), chi-square tests respectively Fisher’s exact tests (when n 5)
were used for dichotomous variables. To test for differences in continuous variables with nor-
mal and non-normal distributions, we used t-tests respectively Mann-Whitney tests. The cor-
relation between TL and age was evaluated using Pearson correlation coefficient. Associations
between TL (dependent variable) and cardiovascular risk factors, lifestyle characteristics, and
other parameters were analyzed using linear regression analyses. Results are shown for unad-
justed and age- and gender-adjusted analyses (Table 2). A p< 0.05 (2 sided) was considered
statistically significant. All statistical calculations were performed using the Statistical Package
for the Social Sciences (SPSS v22.0).
Results
Population characteristics and relationship to telomere length
Baseline demographics, vascular risk factors, laboratory parameters, and T to S ratio in men
and women of the study population, i.e. patients with complete data on TL (N = 343), are pre-
sented in Table 1. TL was slightly and significantly longer in men than in women (0.88 (95%
confidence interval (0.49–1.85)) vs. 0.81 ((95% confidence interval (0.48–1.64)); p = 0.007).
Women had a slightly lower systolic (122.6 ± 7.6 mmHg vs. 126.7 ± 9.4 mmHg; P<0.001) and
diastolic (78.1 ± 5.0 mmHg vs. 80.2 ± 4.4 mmHg; P<0.001) blood pressure, a higher HDL-cho-
lesterol level (64 ± 16 mmol/L vs. 52 ± 12 mmol/L; p<0.001), a higher fibrinogen concentration
(299 (80–694) vs. 260.5 (97–578) μmol/L; p<0.001, Mann-Whitney-U-test) as well as a higher
prevalence of vascular disease (10.6% vs. 2.0%), P = 0.001 and family history of vascular disease
(44.0% vs. 27.1%; p<0.001). The mean values for erythrocytes, hematocrit and hemoglobin
were higher in men (all p< 0.001) and were within the reference values for men and women,
respectively.
As shown in Fig 2, we observed a highly significant inverse association of the T/S ratio (as
surrogate of TL) and chronological age (r = -0.345, P<0.001). Accordingly age explained
approximately 12% of the variability of T/S (r2 = 0.1191).
Cardiovascular risk and telomere length
Other studies have shown an accelerated telomere shortening being related to coronary risk
factors, including obesity, smoking and diabetes mellitus. These effects have been presumed to
be mediated through the increased oxidative stress caused by these factors. We were therefore
interested in the relationship between the Ln-T/S ratio (as surrogate marker of TL) and these
risk factors as well as selected laboratory values.
As shown in Table 2, TL was associated with age (p<0.001) and sex (p = 0.007). Therefore
analyses were adjusted for these covariates (right column in Table 2). In unadjusted models
(left column in Table 2), glucose, total cholesterol and LDL cholesterol, and fibrinogen were
associated with TL. These associations were not seen after adjustments for age and sex. How-
ever several blood cell counts showed significant association with TL even after adjustments:
this was true of red blood cell counts (per 1012/L: Beta: 0.078 (95%-CI (0.007 to 0.149);
p = 0.031), hemoglobin (per 10 g/dL: Beta: 0.322 (95%-CI (0.067 to 0.577)), p = 0.014) and
hematocrit values (per %, Beta: 0.012 (95%-CI (0.003 to 0.022)), p = 0.013). A borderline signif-
icance was observed for an association between TL and thrombocytes (per 1012/L: Beta 0.436
(95%-CI (-0.043 to 0.914)), p = 0.074) and a significant association with white blood cell counts
(per 109/L: Beta: 0.025 (95%-CI (0.006 to 0.044)), p = 0.011. Additionally, one liver enzyme,
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GPT, was significantly inversely associated with TL: per 10 U/L: Beta -0.014 (95%-CI (-0.028 to
-0.001)), p = 0.039).
In a subgroup analysis, we examined the data of all blood donors with no reported vascular
disease (n = 324). As shown in Table 3, results were very similar in this group of apparently
healthy volunteers. Again, in unadjusted models, TL was associated with glucose, total choles-
terol, HDL and LDL cholesterol, fibrinogen and several blood cell counts. However, after
adjustment for age and sex, significant associations remained between TL and haemoglobin
(per 10 g/dL: Beta: 0.320 (95%-CI (0.057 to 0.584)), p = 0.017) and hematocrit (per %: Beta:
0.012 (95%-CI (0.002 to 0.022)), p = 0.023). A borderline significance was observed for an asso-
ciation of TL and red blood cell counts (per 1012/L: Beta: 0.072 (95%-CI (-0.001 to 0.146)),
p = 0.053). While there was no association in unadjusted models, adjustment for age and sex
led to a borderline association of TL with thrombocytes (per 1012/L. Beta 0.432 (95%-CI
(-0.065 to 0.930)), p = 0.088) as well as to a significant association with white blood cell counts
(per 109/L: Beta: 0.027 (95%-CI (0.007 to 0.047)), p = 0.009). Again, an inverse association of
TL and GPT appeared but only at a level of borderline significance: per 10 U/L: Beta: -0.013
(95%-CI (-0.028 to 0.001)), p = 0.076.
Discussion
The observed inverse association between TL and biological age demonstrated here has also
been described in many other studies and confirms the validity of our measurements [22–24].
TL was slightly but significantly longer in men than in women. This result was surprising
because in the majority of other studies on the subject, either TL was found to be slightly longer
in women than in men or no difference was observed [22–24]. The women of this cohort had a
higher than average incidence of familial vascular disease, which may point to a higher genetic
risk that may have contributed to accelerated telomere attrition and thus higher cardiovascular
disease risk. However, the gender difference was very similar in the subgroup of blood donors
without vascular disease (whole group: Beta = 0.075; p = 0.007; subgroup: Beta = 0.064;
p = 0.003). Moreover, it has been shown that the gender difference described in most studies
(TL female> TL male) is smaller at older ages and that smoking and meat consumption may
contribute to these differences [25]. In this context, the relatively low prevalence of smoking
(in both men and women) in our middle-aged population is of interest and may have, at least
partly, contributed to this result. Ethnic diversity between populations or methodological dif-
ferences (Southern blot versus PCR for TL analysis) might also explain the observed differ-
ences. For example, PCR-based methods are less sensitive to possible epigenetic differences
between men and women that may influence recognition sites for restriction endonucleases
used in other methods. It is noteworthy that a different study that also used a PCR-based meth-
odology for measuring TL recently observed longer telomeres in men in another German
cohort of older individuals [26]. On the other hand, not all studies that used PCR-based meth-
odology found longer telomeres in men [24]. Thus methodology is likely not the only explana-
tion for the observed gender difference.
Progressive telomere shortening has been observed in vascular regions susceptible to athero-
sclerosis [27], and may be directly involved in senescence induction. This in turn may, as a pri-
mary abnormality, enhance atherogenesis [28]. Moreover, the chronic systemic inflammation
in atherogenesis may secondarily lead to increased cell turnover and telomere attrition. In this
Fig 1. Telomere length (untransformed) in all patients, n = 343 (A); Telomere length (natural log-
transformed) in all patients, n = 343 (B). T/S was non-normally distributed (A). A natural log-transformation
was performed to obtain a near-normal distribution (B).
doi:10.1371/journal.pone.0139308.g001
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Table 1. Telomere length and baseline characteristics in all patients and stratified by gender, n = 343.
Parameter Total(N = 343) Men(N = 201) Women(N = 142) p Value #
Age in years (min–max) 40.2 ± 12.4(18–71) 39.3 ± 11.7(18–71) 41.6 ± 13.3(19–70) 0.10
T to S ratio (qPCR), untransformed 0.86 (0.48–1.85) 0.88 (0.49–1.85) 0.81 (0.48–1.64) 0.007 MWU-test
T to S ratio (qPCR), natural log-transformed -0.14 ± 0.25 -0.11 ± 0.26 -0.18 ± 0.24 0.007
Smoking, n (%) (n = 342) 76 (22.%) 52 (26.0%) 24 (16.9%) 0.046
Pack-years in smokers (n = 76) 12.0 ± 9.5 12.6 ± 9.4 10.7 ± 9.9 0.42
Body mass index, kg m−2 (n = 340) 24.5 (18.4–41.4) 25.1 (19.2–31.9) 23.5 (18.4–41.4) < 0.001 MWU-test
Obesity (BMI > 30 kg m−2), n (%) (n = 340) 33 (9.7%) 20 (10.1%) 13 (9.2%) 0.77
Glucose, mmol/L (n = 338) 82 (37–332) 84 (37–332) 80 (39–200) 0.15 MWU-test
Hypertension, n (%) 4 (1.2%) 1 (0.5%) 3 (2.1%) 0.31$
Systolic blood pressure, mmHg 125.0 ± 9.0 126.8 ± 9.4 122.4 ± 7.6 <0.001
Diastolic blood pressure, mmHg 79.3 ± 4.8 80.2 ± 4.4 78.1 ± 5.0 <0.001
Cholesterol, mmol/L (n = 338) 196 ± 38 194 ± 35 200 ± 41 0.18
LDL cholesterol, mmol/L (n = 339) 114 ± 32 115 ± 32 113 ± 32 0.56
Hypercholesterolemia (LDL > 130 mmol/L), n (%) (n = 339) 96 (2.38%) 65 (32.5%) 31 (22.3%) 0.040
HDL cholesterol, mmol/L(n = 339) 57 ± 15 52 ± 12 64 ± 16 <0.001
Triglycerides, mmol/L (n = 338) 115 (10–432) 121 (10–432) 106 (36–370) 0.006 MWU-test
Triglycerides > 150 mmol/L + HDL < 50 mmol/L (♀) resp. < 40 mmol/L (♂), n (%) (n = 338) 35 (10.4%) 21 (10.6%) 14 (10.1%) 0.89
Metabolic Syndrome#, n (%) (n = 339) 94 (27.7%) 49 (24.5%) 45 (32.4%) 0.11
Fibrinogen, μmol/L (n = 333) 269 (80–694) 260.5 (97–578) 299 (80–694) < 0.001 MWU-test
Hyperﬁbrinogenemia (ﬁbrinogen > 350 μmol/L), n (%) (n = 333) 52 (15.6%) 18 (9.2%) 34 (24.8%) < 0.001
Creatinine, μmol/L † (n = 337) 0.87 ± 0.16 0.94 ± 0.13 0.76 ± 0.12 < 0.001
GOT, U/L (n = 338) 24 (14–148) 26 (16–137) 22 (14–148) < 0.001 MWU-test
GPT, U/L (n = 338) 18 (2–266) 21 (2–150) 14 (4–266) <0.001 MWU-test
Hemoglobin, g/dL (n = 317) 14.2 ± 1.3 14.9 ± 1.1 13.3 ± 0.9 <0.001
Hematocrit, % (n = 316) 40.4 ± 3.2 41.9 ± 2.9 38.3 ± 2.4 <0.001
Erythrocytes, 1012/L (n = 316) 4.6 ± 0.4 4.8 ± 0.4 4.4 ± 0.3 <0.001
MCV, 10−15 L (n = 317) 87.0 ± 4.0 87.0 ± 3.9 87.1 ± 4.1 0.87
MCH, pg (n = 316) 30.8 (2.5–35.1) 31.1 (24.9–35.1) 30.4 (2.5–34.2) 0.002 MWU-test
MCHC, g/dL (n = 317) 35.2 (30.8–345.6) 35.6 (32.9–345.6) 35.0 (30.8–36.8) <0.001 MWU-test
Leukocytes, 109/L (n = 317) 5.7 ± 1.4 5.5 ± 1.2 5.9 ± 1.5 0.051
Thrombocytes, 109/L (n = 317) 243.1 ± 57.1 228.9 ± 50.1 263.0.0 ± 60.4 <0.001
Vascular disease, % 19 (5.5%) 4 (2.0%) 15 (10.6) 0.001
Positive family history of vascular disease, n (%) (n = 342) 118 (34.5%) 54 (27.0%) 64 (45.1%) 0.001
Count data presented as n(%) and continuous data given as mean ± SD or median (range), respectively
# independent-samples t test respectively Mann-Whitney-U-Test (MWU-test) or the χ2 test
† one outlier removed
$ = Fisher’s Exact Test
BMI = Body mass index
LDL = low density lipoprotein
HDL = high density lipoprotein
GOT = Glutamat-Oxalacetat-Transaminase
GPT = Glutamat-Pyruvat-Transaminase
MCV = Mean corpuscular volume
MCH = Mean corpuscular hemoglobin
MCHC = Mean corpuscular hemoglobin concentration
# = Hyperﬁbrinogenemia and/or obesity and/or triglycerides > 150 mmol/L combined with HDL < 50 mmol/L (♀) resp. < 40 mmol/L (♂).
doi:10.1371/journal.pone.0139308.t001
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Table 2. Influence of risk factors on telomere length (natural log-transformed T/S ratio), results of linear regression models, n = 343.
Independent parameters unadjusted adjusted#
betax 95%-CI p-value betax 95%-CI p-value
Age, per year -0.007 -0.009 to -0.005 < 0.001 - - -
Male vs. female gender 0.075 0.021 to 0.129 0.007 - - -
Smoking, yes vs. no 0.027 -0.038 to 0.092 0.41 0.001 -0.060 to 0.062 0.97
Pack-years, per year (in smokers) 0.008 -0.021 to 0.037 0.53 -0.003 -0.030 to 0.025 0.85
Body mass index, per unit (kg/m2) -0.007 -0.014 to 0.000 0.05 -0.004 -0.011 to 0.003 0.23
Obesity (BMI > 30 kg m−2), yes vs. no -0.024 -0.115 to 0.067 0.60 -0.009 -0.094 to 0.076 0.84
Glucose, per 10 mmol/L -0.012 -0.023 to -0.001 0.033 -0.005 -0.016 to 0.006 0.36
Systolic blood pressure, per 10 mmHg 0.002 -0.028 to 0.032 0.92 0.003 -0.026 to 0.033 0.82
Diastolic blood pressure, per 10 mmHg -0.028 -0.084 to 0.028 0.33 -0.022 -0.076 to 0.033 0.43
Cholesterol, per 10 mmol/L -0.014 -0.021 to– 0.007 < 0.001 -0.004 -0.011 to 0.004 0.36
LDL cholesterol, per 10 mmol/L -0.015 - 0.023 to -0.006 0.001 -0.004 -0.013 to 0.005 0.36
Hypercholesterolemia (LDL > 130 mmol/L), yes vs. no -0.071 -0.130 to -0.011 0.020 -0.015 -0.075 to 0.045 0.62
HDL cholesterol, per 10 mmol/L -0.017 -0.034 to 0.001 0.065 -0.010 -0.028 to 0.008 0.26
Triglycerides, per 10 mmol/L 0.002 -0.002 to 0.005 0.44 0.003 0.000 to 0.007 0.086
Triglycerides > 150 mmol/L + HDL < 50 mmol/L (♀)
resp. < 40 mmol/L (♂), yes vs. no
0.020 -0.070 to 0.109 0.67 0.038 -0.045 to 0.121 0.37
Metabolic Syndrome##, yes vs. no -0.048 -0.108 to 0.012 0.12 0.012 -0.046 to 0.071 0.68
Fibrinogen, per 10 μmol/L -0.005 -0.009 to– 0.002 0.002 -0.002 -0.006 to 0.001 0.22
Hyperﬁbrinogenemia (ﬁbrinogen > 350 μmol/L), yes
vs. no
-0.064 -0.138 to 0.010 0.09 0.014 -0.060 to 0.088 0.72
Creatinine, per 10 μmol/L† 0.012 -0.212 to 0.236 0.92 -0.024 -0.234 to 0.186 0.82
GOT, per 10 U/L -0.001 -0.026 to 0.024 0.94 -0.009 -0.033 to 0.014 0.44
GPT, per 10 U/L -0.011 -0.025 to 0.003 0.13 -0.014 -0.028 to -0.001 0.039
Hemoglobin per 10 g/dL 0.378 0.161 to 0.595 0.001 0.322 0.067 to 0.577 0.014
Hematocrit, per % 0.015 0.006 to 0.024 0.001 0.012 0.003 to 0.022 0.013
Erythrocytes, per 1012/L 0.128 0.063 to 0.193 < 0.001 0.078 0.007 to 0.149 0.031
MCV, per 10 fL -0.058 -0.129 to 0.013 0.11 0.005 -0.064 to 0.073 0.89
MCH, per 10 pg -0.033 -0.151 to 0.085 0.58 0.029 -0.085 to 0.143 0.62
MCHC, per 10 g/dL 0.004 -0.012 to 0.020 0.64 -0.001 -0.016 to 0.015 0.95
Leukocytes, per 109/L 0.013 -0.007 to 0.034 0.21 0.025 0.006 to 0.044 0.011
Thrombocytes, per 1012/L 0.177 -0.317 to 0.672 0.48 0.436 -0.043 to 0.914 0.074
Vascular disease, yes vs. no -0.136 -0.253 to -0.019 0.023 -0.043 -0.156 to 0.071 0.46
Positive family history of vascular disease, yes vs. no -0.059 -0.115 to -0.003 0.041 0.014 -0.043 to 0.071 0.63
#: adjustments for age and sex
CI = conﬁdence interval
† = one outlier removed before regression analyses
BMI = Body mass index
LDL = low density lipoprotein
HDL = high density lipoprotein
GOT = Glutamat-Oxalacetat-Transaminase
GPT = Glutamat-Pyruvat-Transaminase
MCV = Mean corpuscular volume
MCH = Mean corpuscular hemoglobin
MCHC = Mean corpuscular hemoglobin concentration
## = Hyperﬁbrinogenemia and/or obesity and/or triglycerides > 150 mmol/L combined with HDL < 50 mmol/L (♀) resp. < 40 mmol/L (♂).
doi:10.1371/journal.pone.0139308.t002
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study, we did not find a significant association of TL and the occurrence of well-established
cardiovascular risk factors, after adjusting for age and sex. The found associations of TL with
cardiovascular events, cholesterol, and glucose before adjustments for age and sex are likely
caused by age-dependencies and the slightly higher cardiovascular disease risk women in this
cohort demonstrated overall.
Shorter telomeres have been found to be associated with coronary heart disease in many
studies [3–11]. However, much less is known about the relationship between classic coronary
risk factors and TL in apparently healthy people. In accordance with the data described in this
study, Bekaert and co-workers did not find associations between TL and lipid status or blood
pressure in a middle-aged population [20]. In other studies, no relationship has been found
between TL and hypertension [6], body mass index [18,19] or smoking behaviour [18,19] in
apparently healthy individuals. In the Bekaert study, shorter TL was associated with increased
levels of inflammation and oxidative stress markers. In our study, we did not find an associa-
tion with fibrinogen or combined hyperlipidemia with HDL deficiency (as a possible surrogate
for enhanced oxidative stress). We did not however examine direct oxidative stress markers
such as interleukin 6, C-reactive protein or oxidized LDL. Interestingly, Brouilette and co-
workers found shorter TL in 45 healthy offspring of subjects with coronary artery disease
Fig 2. Age and natural log-transformed telomere length, males and females, n = 343. The association of
TL with age, visualized by the regression lines for men (blue circles) and women (green circles), respectively.
doi:10.1371/journal.pone.0139308.g002
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Table 3. Influence of risk factors on telomere length (natural log-transformed T/S ratio), results of linear regressionmodels in patients without vas-
cular disease, n = 324.
Independent parameters unadjusted adjusted#
betax 95%-CI p-value betax 95%-CI p-value
Age, per year -0.007 -0.009 to -0.004 < 0.001 - - -
Male vs. female gender 0.064 0.008 to 0.120 0.003 - - -
Smoking, yes vs. no 0.020 -0,046 to 0.085 0.56 -0.003 -0.065 to 0.060 0.94
Pack-years, per year (in smokers) 0.007 -0.022 to 0.036 0.63 -0.002 -0.030 to 0.025 0.86
Body mass index, per unit (kg/m2) 0.006 -0.013 to 0.001 0.11 -0.004 -0.011 to 0.003 0.28
Obesity (BMI > 30 kg m−2), yes vs. no 0.004 -0.093 to 0.102 0.93 0.007 -0.085 to 0.099 0.88
Glucose, per 10 mmol/L -0.012 -0.024 to -0.001 0.033 -0.005 -0.017 to 0.006 0.34
Systolic blood pressure, per 10 mmHg 0.003 -0.028 to 0.033 0.86 0.004 -0.025 to 0.034 0.77
Diastolic blood pressure, per 10 mmHg -0.021 -0.079 to 0.038 0.49 -0.014 -0.071 to 0.043 0.64
Cholesterol, per 10 mmol/L -0.012 -0.020 to– 0.005 0.001 -0.003 -0.011 to 0.005 0.49
LDL cholesterol, per 10 mmol/L -0.012 - 0.021 to -0.004 0.006 -0.002 -0.012 to 0.007 0.60
Hypercholesterolemia (LDL > 130 mmol/L), yes vs. no -0.056 -0.117 to 0.006 0.078 -0.005 -0.067 to 0.058 0.88
HDL cholesterol, per 10 mmol/L -0.019 -0.037 to -0.001 0.044 -0.013 -0.032 to 0.006 0.17
Triglycerides, per 10 mmol/L 0.002 -0.002 to 0.006 0.37 0.003 -0.001 to 0.007 0.090
Triglycerides > 150 mmol/L + HDL < 50 mmol/L (♀)
resp. < 40 mmol/L (♂), yes vs. no
0.048 -0.046 to 0.142 0.31 0.062 -0.026 to 0.151 0.17
Metabolic Syndrome##, yes vs. no -0.029 -0.092 to 0.034 0.37 0.024 -0.037 to 0.085 0.44
Fibrinogen, per 10 μmol/L -0.005 -0.008 to– 0.001 0.007 -0.002 -0.005 to 0.002 0.38
Hyperﬁbrinogenemia (ﬁbrinogen > 350 μmol/L), yes
vs. no
-0.056 -0.133 to 0.021 0.16 0.018 -0.060 to 0.095 0.65
Creatinine, per 10 μmol/L† -0.001 -0.224 to 0.223 0.99 -0.027 -0.239 to 0.185 0.80
GOT, per 10 U/L -0.002 -0.027 to 0.024 0.90 -0.009 -0.033 to 0.016 0.49
GPT, per 10 U/L -0.010 -0.025 to 0.005 0.20 -0.013 -0.028 to 0.001 0.076
Hemoglobin, per 10 g/dL 0.345 0.124 to 0.566 0.002 0.320 0.057 to 0.584 0.017
Hematocrit, per % 0.014 0.005 to 0.023 0.003 0.012 0.002 to 0.022 0.023
Erythrocytes, per 1012/L 0.114 0.048 to 0.181 0.001 0.072 -0.001 to 0.146 0.053
MCV, per 10 fL -0.048 -0.121 to 0.024 0.19 0.007 -0.064 to 0.078 0.84
MCH, per 10 pg -0.020 -0.139 to 0.098 0.74 0.037 -0.079 to 0.153 0.53
MCHC, per 10 g/dL 0.004 -0.013 to 0.020 0.67 0.000 -0.015 to 0.015 0.97
Leukocytes, per 109/L 0.015 -0.006 to 0.036 0.17 0.027 0.007 to 0.047 0.009
Thrombocytes, per 1012/L 0.237 -0.272 to 0.745 0.36 0.432 -0.065 to 0.930 0.088
Positive family history of vascular disease, yes vs. no -0.038 -0.097 to -0.021 0.21 0.022 -0.037 to 0.081 0.46
#: adjustments for age and sex
CI = conﬁdence interval
† = one outlier removed before regression analyses
BMI = Body mass index
LDL = low density lipoprotein
HDL = high density lipoprotein
GOT = Glutamat-Oxalacetat-Transaminase
GPT = Glutamat-Pyruvat-Transaminase
MCV = Mean corpuscular volume
MCH = Mean corpuscular hemoglobin
MCHC = Mean corpuscular hemoglobin concentration
## = Hyperﬁbrinogenemia and/or obesity and/or triglycerides > 150 mmol/L combined with HDL < 50 mmol/L (♀) resp. < 40 mmol/L (♂).
doi:10.1371/journal.pone.0139308.t003
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compared to 59 offspring from families without such a history [29]. In contrast, our study
found no such relationship between TL and positive family history of vascular disease after
adjusting for age and sex. These data are in accordance with the Asklepios study, in which no
shorter telomere length could be found in healthy subjects with a family history of cardiovascu-
lar disease [30].
At least three possible explanations can account for discrepant results in apparently healthy
individuals versus atherosclerotic patients. First, the power of this and other studies with nega-
tive results might be too low to detect minor differences. Second, the telomere attrition may
provide an independent mechanism for the development of cardiovascular conditions and is
not a reflection of the presence of established coronary risk factors. In this scenario the coinci-
dence of telomere attrition and prevalence of other risk factors would not reflect a causal rela-
tionship. Third, telomere attrition happens at a relatively late event in chronic stress response,
perhaps making is as yet undetectable in our healthy subject group.
Apart from classic coronary risk factors, we also selected emerging risk factors including
creatinine, transaminases and blood cell counts to explore possible connections with TL. We
found that TL was positively associated with erythrocyte and leukocyte count, haematocrit,
and hemoglobin. A borderline association was found between TL and thrombocytes (Table 2).
Altogether these data suggest that telomere attrition may be a marker for reduced global cellu-
lar reserve in this population.
Recent reports suggested an association between TL and blood cell counts. Anemia was
found to be associated with shorter leukocyte TL in patients with heart failure [31]. De Meyer
et al. found a positive association of TL and red blood cell count but no significant association
of TL and haematocrit, haemoglobin or leukocytes in middle-aged subjects in the Asklepios
study [32]. In contrast to our study, these authors found shorter TLs to be associated with
increased MCV. In the Dallas Heart study, Kozlitina et al. also found a positive association of
TL with red blood cell count and a negative association of TL and MCV, using a multiple
regression model in a multi-ethnic population [33].
Conflicting results have similarly been described for leukocytes. Gutmajster and colleagues
have seen an association of white blood cell count and TL in elderly Caucasians [34] and Auli-
nas et al. have seen such a correlation in patients with hypercortisolism [35]. By contrast, Satoh
and co-workers were unable to show an association between TL and leukocyte count [36].
The origin of these differences might be rooted in varying study populations, ethnic diver-
sity, methodological differences, a limited number of study participants, and lack of adjustment
for possible modifiers of hematological blood values (such as thyroid stimulating hormone,
folate, vitamin B12 and erythropoietin levels).
This study has some limitations. First, we cannot entirely exclude the possibility that blood
donations made previous to the beginning of our study may have influenced the results, partic-
ularly regarding blood cells. It is unlikely, however, that this is the only explanation for our
findings. Anemic individuals were excluded from blood donation and the relationship between
TL and red or white blood cells (despite the described conflicting results) have previously been
seen in other populations. Second, the cohort is heterogeneous and cardiovascular risk factors
are unequally distributed among men and women. On the other hand, we observed very similar
results in the subgroup without vascular disease. Overall, data are plausible insofar as we found
significant associations of TL with both major cell lines, a borderline association with the
megakaryocytic cell line, and associations with hemoglobin and hematocrit but no association
with any of the established cardiovascular risk factors.
In summary, the data described here do not support the concept that coronary risk factors
resulted in increased cell turnover and telomere attrition in a blood donor population. Whether
TL could serve as a global biomarker of vascular risk, or if it may play a role as an independent
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risk factor remains to be determined in prospective studies. Telomere attrition may be a marker
for reduced global cellular proliferation reserve.
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